These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22293889)

  • 1. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Haber P; Tate J; Marquez PL; Moro PL; Parashar U
    Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
    Haber P; Parashar UD; Haber M; DeStefano F
    Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
    Haber P; Patel M; Pan Y; Baggs J; Haber M; Museru O; Yue X; Lewis P; Destefano F; Parashar UD
    Pediatrics; 2013 Jun; 131(6):1042-9. PubMed ID: 23669521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
    Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE;
    Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.
    Niu MT; Erwin DE; Braun MM
    Vaccine; 2001 Sep; 19(32):4627-34. PubMed ID: 11535310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.
    Verstraeten T; Baughman AL; Cadwell B; Zanardi L; Haber P; Chen RT;
    Am J Epidemiol; 2001 Dec; 154(11):1006-12. PubMed ID: 11724716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in 5 African Countries.
    Tate JE; Mwenda JM; Keita AM; Tapsoba TW; Ngendahayo E; Kouamé BD; Samateh AL; Aliabadi N; Sissoko S; Traore Y; Bayisenga J; Sounkere-Soro M; Jagne S; Burke RM; Onwuchekwa U; Ouattara M; Bikoroti JB; N'Zue K; Leshem E; Coulibaly O; Ouedraogo I; Uwimana J; Sow S; Parashar UD;
    Clin Infect Dis; 2024 Jan; 78(1):210-216. PubMed ID: 37596934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.